Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Irritable Bowel Syndrome, May 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 65 articles: HTML format

Single Articles

1. ABRAHAM P, Pratap N
   Dysbiosis in Irritable Bowel Syndrome.
   J Assoc Physicians India. 2023;71:75-81.
   PubMed    
   Abstract available
   
   

2. ZHAO L, Zhang T, Zhang K
   Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system.
   Front Immunol. 2024;15:1353614.
   PubMed    
   Abstract available
   
   

3. TIKHOMIROVA A, McNabb ER, Petterlin L, Bellamy GL, et al
   Campylobacter jejuni virulence factors: update on emerging issues and trends.
   J Biomed Sci. 2024;31:45.
   PubMed    
   Abstract available
   
   

4. ZINK N
   [Not Available].
   MMW Fortschr Med. 2024;166:10.
   PubMed    
   
   
   

5. VALIBOUZE C, Dubuquoy C, Chavatte P, Genin M, et al
   Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
   World J Gastroenterol. 2024;30:2258-2271.
   PubMed    
   Abstract available
   
   

6. DAI C, Huang YH, Jiang M
   Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
   World J Gastroenterol. 2024;30:2179-2183.
   PubMed    
   Abstract available
   
   

7. HILLESTAD EMR, Steinsvik EK, Teige ES, Rasmussen SH, et al
   Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.
   Neurogastroenterol Motil. 2024 Apr 30:e14814. doi: 10.1111/nmo.14814.
   PubMed    
   Abstract available
   
   

8. PATHIPATI MP, Scott LL, Griser AC, Staller K, et al
   Real-world outcomes for a digital prescription mobile application for adults with irritable bowel syndrome.
   Neurogastroenterol Motil. 2024 Apr 30:e14811. doi: 10.1111/nmo.14811.
   PubMed    
   Abstract available
   
   

9. NYBOE ANDERSEN N, Wildt S, Iversen AT, Poulsen G, et al
   Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
   BMJ Open Gastroenterol. 2024;11:e001340.
   PubMed    
   Abstract available
   
   

10. MOHAMMED C, Fuego JP, Garcia KV, Jamil H, et al
    A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights.
    Cureus. 2024;16:e57055.
    PubMed    
    Abstract available
    
    

11. CHOI Y, Ha NY, Kim AR, Jeong H, et al
    Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial.
    Int J Gen Med. 2024;17:1545-1556.
    PubMed    
    Abstract available
    
    

12. RAY G, Ghoshal UC
    Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.
    Gut Liver. 2024 Apr 29. doi: 10.5009/gnl230396.
    PubMed    
    Abstract available
    
    

13. O'DONNELL MT, Haviland SM
    Functional Constipation and Obstructed Defecation.
    Surg Clin North Am. 2024;104:565-578.
    PubMed    
    Abstract available
    
    

14. TORRES-MARAVILLA E, Carvalho FA, Holowacz S, Delannoy J, et al
    Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
    Benef Microbes. 2024 Apr 30:1-18. doi: 10.1163/18762891-bja00006.
    PubMed    
    Abstract available
    
    

15. JIA F, Du L, He J, Zhang Z, et al
    Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    J Ethnopharmacol. 2024 Apr 25:118256. doi: 10.1016/j.jep.2024.118256.
    PubMed    
    Abstract available
    
    

16. SERRA J, Aguilar A, Barba E, de Los Rios CC, et al
    ASOCIACION ESPANOLA DE NEUROGASTROENTEROLOGIA Y MOTILIDAD (ASENEM) UPDATED REVIEW ON THE MANAGEMENT OF FUNCTIONAL ABDOMINAL PAIN.
    Gastroenterol Hepatol. 2024 Apr 25:S0210-5705(24)00145.
    PubMed    
    Abstract available
    
    

17. WADE U, Pascual-Figal DA, Rabbani F, Ernst M, et al
    The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
    Nutrients. 2024;16:1204.
    PubMed    
    Abstract available
    
    

18. MAHDI T, Desmons A, Krasniqi P, Lacorte JM, et al
    Effect of Stool Sampling on a Routine Clinical Method for the Quantification of Six Short Chain Fatty Acids in Stool Using Gas Chromatography-Mass Spectrometry.
    Microorganisms. 2024;12:828.
    PubMed    
    Abstract available
    
    

19. CHIMIENTI G, Russo F, Bianco A, Maqoud F, et al
    Effect of a 12-Week Walking Program Monitored by Global Physical Capacity Score (GPCS) on Circulating Cell-Free mtDNA and DNase Activity in Patients with Irritable Bowel Syndrome.
    Int J Mol Sci. 2024;25:4293.
    PubMed    
    Abstract available
    
    

20. SAROJ A, Tripathi A, Rungta S, Kar SK, et al
    Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India.
    Brain Sci. 2024;14:393.
    PubMed    
    Abstract available
    
    

21. NOJKOV B, Burnett C, Watts L, Yin J, et al
    The impact of transcutaneous electrical acustimulation (TEA) on rectal distension-induced pain in patients with irritable bowel syndrome (IBS)-A study to determine the optimal TEA delivery modalities and effects on rectal sensation and autonomic funct
    Neurogastroenterol Motil. 2024 Apr 26:e14799. doi: 10.1111/nmo.14799.
    PubMed    
    Abstract available
    
    

22. CARABOTTI M, Marasco G, Sbarigia C, Cuomo R, et al
    Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients.
    Intern Emerg Med. 2024 Apr 27. doi: 10.1007/s11739-024-03588.
    PubMed    
    Abstract available
    
    

23. ZHANG S, Tian D, Xia Z, Yang F, et al
    Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-kappaB/NLRP3 pathway.
    J Ethnopharmacol. 2024;330:118236.
    PubMed    
    Abstract available
    
    

24. YANG S, Liu H, Li K, Chen B, et al
    Research in revealing the effects on Cuscuta chinensis to diarrhea type irritable bowel syndrome based on network pharmacology and molecular docking potential mechanism.
    Medicine (Baltimore). 2024;103:e38113.
    PubMed    
    Abstract available
    
    

25. ALSHAIKH AA, Alamri SM, Riaz F, Mahmood SE, et al
    Exploring the burden of irritable bowel syndrome among university students in Saudi Arabia: A study on prevalence, psychological associations, and well-being.
    Medicine (Baltimore). 2024;103:e38099.
    PubMed    
    Abstract available
    
    

26. NOEMI CN, Bob P, Bokkon I
    Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS.
    Curr Neuropharmacol. 2024 May 9. doi: 10.2174/1570159X22666240507095700.
    PubMed    
    Abstract available
    
    

27. VALLADARES-GARRIDO MJ, Zapata-Castro LE, Quiroga-Castaneda PP, Berrios-Villegas I, et al
    Irritable bowel syndrome and erectile dysfunction in medical students at a Peruvian university: an analytical cross-sectional analysis.
    Sex Med. 2024;12:qfae021.
    PubMed    
    Abstract available
    
    

28. ANSARI AZ, Hafeez S, Jung J, Patibandla S, et al
    Chronic Idiopathic Ulcers Mimicking Cecal Carcinoma: A Case Report.
    Cureus. 2024;16:e57792.
    PubMed    
    Abstract available
    
    

29. MARTIN FP, Cominetti O, Berger B, Combremont S, et al
    Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic.
    Gut Microbes. 2024;16:2347715.
    PubMed    
    Abstract available
    
    

30. TETALI B, Suresh S
    Management of irritable bowel syndrome: a narrative review.
    Transl Gastroenterol Hepatol. 2024;9:26.
    PubMed    
    Abstract available
    
    

31. MURALIDHAR V, Kundhavai C, Modiem R, Sowmya S, et al
    Paravertebral retroperitoneal ancient schwannoma mimicking irritable bowel syndrome.
    J Surg Case Rep. 2024;2024:rjae283.
    PubMed    
    Abstract available
    
    

32. KHALIGHI SIKAROUDI M, Soltani S, Ghoreishy SM, Ebrahimi Z, et al
    Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials.
    Food Funct. 2024 May 7. doi: 10.1039/d3fo03717.
    PubMed    
    Abstract available
    
    

33. ALMUZAINI AS, Almuzaini R, Alsaleem HN, Alsuhaibani A, et al
    Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among General Population: A Cross-Sectional Study in Qassim Region, Saudi Arabia.
    Cureus. 2024;16:e57493.
    PubMed    
    Abstract available
    
    

34. KESZTHELYI D
    Organic versus functional dichotomy in gastroenterology: Are we ready to move the needle?
    United European Gastroenterol J. 2024 May 17. doi: 10.1002/ueg2.12588.
    PubMed    
    
    
    

35. JENT S, Bez NS, Haddad J, Catalano L, et al
    The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis.
    Clin Nutr. 2024;43:1551-1562.
    PubMed    
    Abstract available
    
    

36. YING J, Ye D, Luo P, Liu B, et al
    Lifestyle and genetic predisposition are associated with incident irritable bowel syndrome: A population-based prospective cohort study.
    Clin Nutr. 2024;43:1544-1550.
    PubMed    
    Abstract available
    
    

37. UMEANO L, Iftikhar S, Alhaddad SF, Paulsingh CN, et al
    Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.
    Cureus. 2024;16:e58306.
    PubMed    
    Abstract available
    
    

38. TAWDE P, Walters OC, Salwen-Deremer JK
    Gut-Directed Hypnotherapy May Pose Specific Challenges in Gender-Diverse Patients: A Review of 3 Patients.
    ACG Case Rep J. 2024;11:e01355.
    PubMed    
    Abstract available
    
    

39. TANG KT, Chen DY, Chen YH
    A study on irritable bowel syndrome, temporomandibular disorder, and restless leg syndrome in Chinese patients with fibromyalgia.
    Int J Rheum Dis. 2024;27:e15149.
    PubMed    
    
    
    

40. WANG Y, Peng W, Liang D
    Ultra-Processed Food Consumption and Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2024 May 13:S1542-3565(24)00445.
    PubMed    
    
    
    

41. SUGAYA N
    Work-related problems and the psychosocial characteristics of individuals with irritable bowel syndrome: an updated literature review.
    Biopsychosoc Med. 2024;18:12.
    PubMed    
    Abstract available
    
    

42. FRIELING T, Gjini B, Melchior I, Euler P, et al
    Gastrointestinal adverse reaction to food (GARF) and endoscopic confocal laser endomicroscopy (eCLE).
    Z Gastroenterol. 2024 May 15. doi: 10.1055/a-2258-8509.
    PubMed    
    Abstract available
    
    

43. LOKHAMMER S, Koller D, Wendt FR, Choi KW, et al
    Distinguishing vulnerability and resilience to posttraumatic stress disorder evaluating traumatic experiences, genetic risk and electronic health records.
    Psychiatry Res. 2024;337:115950.
    PubMed    
    Abstract available
    
    

44. MPAKOGIANNIS K, Fousekis FS, Katsanos AH, Katsanos KH, et al
    Can Hypnotherapy Be Considered a Valuable Component in the Management of Inflammatory Bowel Disease? Insights from a Comprehensive Review.
    Int J Clin Exp Hypn. 2024 May 14:1-15. doi: 10.1080/00207144.2024.2350460.
    PubMed    
    Abstract available
    
    

45. XU C, Song Z, Hu JY, Li CC, et al
    Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.
    J Health Popul Nutr. 2024;43:63.
    PubMed    
    Abstract available
    
    

46. HEARN-YEATES F, Horne AW, O'Mahony S, Saunders PTK, et al
    The impact of the microbiota-gut-brain axis on endometriosis-associated symptoms: mechanisms and opportunities for personalised management strategies.
    Reprod Fertil. 2024 May 1:RAF-23-0085. doi: 10.1530/RAF-23-0085.
    PubMed    
    Abstract available
    
    

47. LI D, Du H, Qu ST, Wu JL, et al
    Thalamic Nucleus Reuniens Glutamatergic Neurons Mediate Colorectal Visceral Pain in Mice via 5-HT(2B) Receptors.
    Neurosci Bull. 2024 May 13. doi: 10.1007/s12264-024-01207.
    PubMed    
    Abstract available
    
    

48. THUMANN TA, Pferschy-Wenzig E-M, Kumpitsch C, Duller S, et al
    Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.
    Microbiol Spectr. 2024 May 13:e0403123. doi: 10.1128/spectrum.04031.
    PubMed    
    Abstract available
    
    

49. MOTAGHI P, Adibi I, Adibi P, Ghasemi M, et al
    Small fiber neuropathy in irritable bowel syndrome.
    Gastroenterol Hepatol Bed Bench. 2024;17:57-63.
    PubMed    
    Abstract available
    
    

50. MAINDAD GG, Baravkar P, Padwal M, Maindad D, et al
    Bibliometric Analysis of the Highly Cited Articles on Biomarker Discovery for Irritable Bowel Syndrome from 1985 to 2023.
    J Assoc Physicians India. 2024;72:36-39.
    PubMed    
    Abstract available
    
    

51. WATANABE H, Inoue T, Miyamoto L, Ono Y, et al
    Changes in intestinal microbiota and biochemical parameters in patients with inflammatory bowel disease and irritable bowel syndrome induced by the prolonged addition of soluble fibers to usual drug therapy.
    J Med Invest. 2024;71.
    PubMed    
    Abstract available
    
    

52. ZHANG MM, Dang M, Wu X, Ou L, et al
    Da-Jian-Zhong decoction alleviates diarrhea-predominant irritable bowel syndrome via modulation of gut microbiota and Th17/Treg balance.
    J Ethnopharmacol. 2024;331:118275.
    PubMed    
    Abstract available
    
    

53. ESWARAN S, Jencks KJ, Singh P, Rifkin S, et al
    All FODMAPs aren't created equal: Results of a randomized reintroduction trial in patients with irritable bowel syndrome.
    Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00413.
    PubMed    
    Abstract available
    
    

54. HEDMAN-LAGERLOF M, Gasslander N, Ahnlund Hoffmann A, Bragesjo M, et al
    Effect of exposure-based vs traditional cognitive behavior therapy for fibromyalgia: a two-site single-blind randomized controlled trial.
    Pain. 2024;165:1278-1288.
    PubMed    
    Abstract available
    
    

55. TUNALI V, Arslan NC, Ermis BH, Hakim GD, et al
    A Multicenter Randomized Controlled Trial Of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet Vs Low Fodmap Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002862.
    PubMed    
    Abstract available
    
    

56. SAUL H, Cassidy S, Swaithes L, Ford A, et al
    Irritable bowel syndrome: low dose antidepressant improves symptoms.
    BMJ. 2024;385:q871.
    PubMed    
    Abstract available
    
    

57. TAKAKURA W, Singh P
    Concise Commentary: Bloating in IBS: Can We Burst the Bubble?
    Dig Dis Sci. 2024;69:1739.
    PubMed    
    
    
    

58. GWEE KA
    The Challenge of Managing IBS in the Real World: Dogma, Dictates, Denials.
    Dig Dis Sci. 2024;69:1524-1526.
    PubMed    
    
    
    

59. KOMORI S, Akiyama J, Tatsuno N, Yamada E, et al
    Prevalence and Risk Factors of Constipation Symptoms among Patients Undergoing Colonoscopy: A Single-Center Cross-Sectional Study.
    Digestion. 2024 May 16. doi: 10.1159/000539366.
    PubMed    
    Abstract available
    
    

60. FORD AC, Staudacher HM, Talley NJ
    Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
    Gut. 2024 May 2:gutjnl-2023-331833. doi: 10.1136/gutjnl-2023-331833.
    PubMed    
    Abstract available
    
    

61. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    PubMed    
    Abstract available
    
    

62. VAN DER MEULEN ML, Bos M, Bakker SJL, Gans ROB, et al
    Validity and diagnostic overlap of functional somatic syndrome diagnoses.
    J Psychosom Res. 2024;181:111673.
    PubMed    
    Abstract available
    
    

63. TATTAN M, Ornbol E, Wellnitz KB, Hanssen DJC, et al
    Factors associated with having previously received a diagnosis of fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome: A cross sectional DanFunD study.
    J Psychosom Res. 2024 May 5:111693. doi: 10.1016/j.jpsychores.2024.111693.
    PubMed    
    Abstract available
    
    

64. MCGHIE-FRASER B, McLoughlin C, Lucassen P, Ballering A, et al
    Measuring persistent somatic symptom related stigmatisation: Development of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP).
    J Psychosom Res. 2024 Apr 30:111689. doi: 10.1016/j.jpsychores.2024.111689.
    PubMed    
    Abstract available
    
    

65. REGNATH F, Biersack K, Schroder L, Stainer MC, et al
    Experimental evidence for a robust, transdiagnostic marker in functional disorders: Erroneous sensorimotor processing in functional dizziness and functional movement disorder.
    J Psychosom Res. 2024 May 5:111694. doi: 10.1016/j.jpsychores.2024.111694.
    PubMed    
    Abstract available